Cargando…

VhH anti‐thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow

BACKGROUND: Thrombomodulin on endothelial cells can form a complex with thrombin. This complex has both anticoagulant properties, by activating protein C, and clot‐protective properties, by activating thrombin‐activatable fibrinolysis inhibitor (TAFI). Activated TAFI (TAFIa) inhibits plasmin‐mediate...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Moorsel, Marc V. A., Poolen, Geke C., Koekman, Cornelis A., Verhoef, Sandra, de Maat, Steven, Barendrecht, Arjan, van Kleef, Nadine D., Meijers, Joost C. M., Schiffelers, Raymond M., Maas, Coen, Urbanus, Rolf T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	FIBRINOLYSIS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311061/ https://www.ncbi.nlm.nih.gov/pubmed/35170225 http://dx.doi.org/10.1111/jth.15674

Ejemplares similares

Fibrinolysis in a lipid environment: modulation through release of free fatty acids
por: RÁBAI, G, et al.
Publicado: (2007)

Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis
por: Mutch, N J, et al.
Publicado: (2010)

Pharmacokinetics of Recombinant Human Soluble Thrombomodulin in Disseminated Intravascular Coagulation Patients with Acute Renal Dysfunction
por: Hayakawa, Mineji, et al.
Publicado: (2017)

A head-to-head comparison of conjugation methods for VHHs: Random maleimide-thiol coupling versus controlled click chemistry
por: van Moorsel, Marc V.A., et al.
Publicado: (2019)

Hindered dissolution of fibrin formed under mechanical stress
por: Varjú, I, et al.
Publicado: (2011)

Lytic and mechanical stability of clots composed of fibrin and blood vessel wall components
por: Rottenberger, Z, et al.
Publicado: (2013)

Leukemia‐associated Rho guanine‐nucleotide exchange factor is not critical for RhoA regulation, yet is important for platelet activation and thrombosis in mice
por: Williams, C. M., et al.
Publicado: (2015)

Increased urokinase and consumption of α(2)‐antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay
por: Longstaff, C., et al.
Publicado: (2018)

On the localization of the cleavage site in human alpha‐2‐antiplasmin, involved in the generation of the non‐plasminogen binding form
por: Abdul, Shiraazkhan, et al.
Publicado: (2020)

Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review
por: Sillen, Machteld, et al.
Publicado: (2021)

Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI)
por: Valnickova, Zuzana, et al.
Publicado: (2009)

Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission
por: ERDOĞAN, Mehmet, et al.
Publicado: (2019)

Long-Acting Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Children: Results of a Phase 3 Trial
por: Kenet, Gili, et al.
Publicado: (2016)

Polyphosphate Delays Fibrin Polymerisation and Alters the Mechanical Properties of the Fibrin Network
por: Whyte, Claire S., et al.
Publicado: (2016)

Impact of Fibrinogen Carbamylation on Fibrin Clot Formation and Stability
por: Binder, Veronika, et al.
Publicado: (2017)

Are Cardiovascular Risk Factors also Associated with the Incidence of Atrial Fibrillation?: A Systematic Review and Field Synopsis of 23 Factors in 32 Population-Based Cohorts of 20 Million Participants
por: Allan, Victoria, et al.
Publicado: (2017)

Platelet Turnover Predicts Outcome after Coronary Intervention
por: Freynhofer, Matthias K., et al.
Publicado: (2017)

Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic
por: Patel, Rachna, et al.
Publicado: (2021)

VHH CDR-H3 conformation is determined by VH germline usage
por: Bahrami Dizicheh, Zahra, et al.
Publicado: (2023)

Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke
por: Kraft, Peter, et al.
Publicado: (2010)

Heparin Forms Polymers with Cell-free DNA Which Elongate Under Shear in Flowing Blood
por: de Vries, Joost C., et al.
Publicado: (2019)

Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge
por: Kim, Hyun Kyung
Publicado: (2010)

Dose-Response Relationship Between Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) and Stroke: A Chinese Case-Control Study
por: Dai, Huixu, et al.
Publicado: (2017)

Heating as a rapid purification method for recovering correctly-folded thermotolerant VH and VHH domains
por: Olichon, Aurelien, et al.
Publicado: (2007)

Targeted SERPIN (TaSER): A dual‐action antithrombotic agent that targets platelets for SERPIN delivery
por: Sanrattana, Wariya, et al.
Publicado: (2021)

THE EFFECT OF THE COVID-19 PANDEMIC PROCESS ON TREATMENT COMPLIANCE IN HEMOPHILIA PATIENTS
por: Şahin, Şifa, et al.
Publicado: (2022)

Pharmacological Differentiation of Thrombomodulin Alfa and Activated Protein C on Coagulation and Fibrinolysis In Vitro
por: Tanaka, Kosuke, et al.
Publicado: (2018)

Visualization of Domain- and Concentration-Dependent Impact of Thrombomodulin on Differential Regulation of Coagulation and Fibrinolysis
por: Mochizuki, Liina, et al.
Publicado: (2022)

Altered fibrin network structure and fibrinolysis in intensive care unit patients with COVID‐19, not entirely explaining the increased risk of thrombosis
por: de Vries, Judith J., et al.
Publicado: (2022)

Increased Thrombin-Activatable Fibrinolysis Inhibitor and Decreased Tissue Factor Pathway Inhibitor and Thrombomodulin Levels in Children with Hypothyroidism
por: Alioğlu, Bülent, et al.
Publicado: (2012)

Study of Coagulopathies in Covid 19 Positive Patients & Their Correlation with Outcome of Disease
por: Khunger, Jitender, et al.
Publicado: (2020)

VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study
por: Madeeva, Daria V, et al.
Publicado: (2020)

COVID-19 in Relation to Hematological Events (Thrombosis/Bleeding) and Mortality in Inpatient Setting
por: Gadde, Saikrishna, et al.
Publicado: (2020)

Plasma Exchange for COVID-19 Thrombo-Inflammatory Disease
por: Thomas, Mari, et al.
Publicado: (2020)

Venous Thromboembolic Disease in Children Associated with COVID-19
por: Narang, Shalu, et al.
Publicado: (2020)

Coagulation Dysfunction and Hematological Changes in 633 Patients with COVID-19
por: Yang, Mo, et al.
Publicado: (2020)

Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study
por: Crowther, Mark, et al.
Publicado: (2020)

GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery
por: van Schie, Loes, et al.
Publicado: (2023)

Alternative SET/TAFI Promoters Regulate Embryonic Stem Cell Differentiation
por: Edupuganti, Raghu Ram, et al.
Publicado: (2017)

Identification of Genes and miRNAs Associated with TAFI-Related Thrombosis: An in Silico Study
por: Rouka, Erasmia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ec8ic5sih0lohg73oicvodv7en